Perioperative Ketorolac-lidocaine in the Patients With Valvular Heart Diseases During Cesarean Delivery
A Randomized Study of the Effects of Perioperative i.v. Ketorolac-lidocaine on the Hemodynamic Response in the Patients With Valvular Heart Diseases During Cesarean Delivery
Sponsor: Mansoura University
Suspended
No enough recruited cases
A PHASE2 clinical study on Elective Cesarean Delivery and Valve Heart Disease, this trial is suspended. The trial is conducted by Mansoura University and has accumulated 8 data snapshots since 2012. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.
Status Flow
Change History
8 versions recorded-
Sep 2025 — Present [monthly]
Suspended PHASE2
-
Sep 2024 — Sep 2025 [monthly]
Suspended PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Suspended PHASE2
-
Jan 2021 — Jul 2024 [monthly]
Suspended PHASE2
-
Oct 2020 — Jan 2021 [monthly]
Suspended PHASE2
Status: Unknown Status → Suspended
▶ Show 3 earlier versions
-
Jun 2018 — Oct 2020 [monthly]
Unknown Status PHASE2
-
May 2017 — Jun 2018 [monthly]
Unknown Status PHASE2
Status: Recruiting → Unknown Status
-
Jan 2017 — May 2017 [monthly]
Recruiting PHASE2
First recorded
Jun 2012
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Mansoura University
For direct contact, visit the study record on ClinicalTrials.gov .